Skip to main content
Fig. 6 | Pediatric Rheumatology

Fig. 6

From: Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study

Fig. 6

Association between estimated IFX clearance and identified clinical covariates. Estimated IFX clearance values are stratified and presented based on (a) ADA positivity by GRA, (b) serum albumin concentrations, and (c) ESR. Data is plotted as box and whisker plots and evaluated by unpaired analysis using the Wilcoxon rank-sum test and the resulting p-values are provided

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096